Four questions about Biden’s Covid-19 diagnosis
Experts say the president’s case is likely to stay mild.
Today's Liberal News
By Sarah Owermohle and Adam Cancryn
Four questions about Biden’s Covid-19 diagnosis
Experts say the president’s case is likely to stay mild.
Four questions about Biden’s Covid-19 diagnosis
Experts say the president’s case is likely to stay mild.
Four questions about Biden’s Covid-19 diagnosis
Experts say the president’s case is likely to stay mild.
Bad Covid winter brings questions about what’s ‘fully vaccinated’
Discussions within the administration are focused on whether a third shot should be considered part of the original Covid-19 vaccine regimen.
Bad Covid winter brings questions about what’s ‘fully vaccinated’
Discussions within the administration are focused on whether a third shot should be considered part of the original Covid-19 vaccine regimen.
Biden will require vaccines for staff at federally funded nursing homes
It’s the first time the White House has used the threat of holding back federal funding to boost vaccination rates.
Biden will require vaccines for staff at federally funded nursing homes
It’s the first time the White House has used the threat of holding back federal funding to boost vaccination rates.
Biden will require vaccines for staff at federally funded nursing homes
It’s the first time the White House has used the threat of holding back federal funding to boost vaccination rates.
Biden will require vaccines for staff at federally funded nursing homes
It’s the first time the White House has used the threat of holding back federal funding to boost vaccination rates.
Biden will require vaccines for staff at federally funded nursing homes
It’s the first time the White House has used the threat of holding back federal funding to boost vaccination rates.
FDA targets early September for approving Pfizer’s Covid-19 vaccine
Officials have recently accelerated their work and now hope to finalize approval in a matter of weeks.
FDA targets early September for approving Pfizer’s Covid-19 vaccine
Officials have recently accelerated their work and now hope to finalize approval in a matter of weeks.
Biden administration to buy 500M Pfizer doses for global distribution
President Joe Biden will announce the plan tomorrow ahead of the G-7 meeting in the United Kingdom.
Biden administration to buy 500M Pfizer doses for global distribution
President Joe Biden will announce the plan tomorrow ahead of the G-7 meeting in the United Kingdom.
Biden administration to buy 500M Pfizer doses for global distribution
President Joe Biden will announce the plan tomorrow ahead of the G-7 meeting in the United Kingdom.
Biden to order 100M more doses of Johnson & Johnson vaccine
The planned purchase would bring the country’s total vaccine order to 800 million doses split among three manufacturers.
Biden accelerates vaccination timeline after manufacturing deal
The Biden administration helped broker the deal after reports earlier this year that J&J was struggling with production delays.
New virus variants threaten Biden’s pandemic plans
The government is already collaborating with Moderna to develop vaccine booster shots aimed at strains first identified in South Africa and the United Kingdom.
New virus variants threaten Biden’s pandemic plans
The government is already collaborating with Moderna to develop vaccine booster shots aimed at strains first identified in South Africa and the United Kingdom.
New virus variants threaten Biden’s pandemic plans
The government is already collaborating with Moderna to develop vaccine booster shots aimed at strains first identified in South Africa and the United Kingdom.
FDA fights for independence in Trump administration’s final days
Health and Human Services is trying to jam through an industry-backed plan to effectively strip FDA oversight of genetically modified animals.